跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
PERISYL COMBI 2/0.625 perindopril erbumine/indapamide hemihydrate 2mg/0.625mg tablet blister pack
Approved
STANDARD
PERISYL COMBI 2/0.625 perindopril erbumine/indapamide hemihydrate 2mg/0.625mg tablet blister pack
Alphapharm Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
d2b7a8b82ac1aef6
Company
Alphapharm Pty Ltd
Type
Standard
Approval Details
Approval Id
d2b7a8b82ac1aef6
Product Name
PERISYL COMBI 2/0.625 perindopril erbumine/indapamide hemihydrate 2mg/0.625mg tablet blister pack
Artg Id
179753
Artg Name
PERISYL COMBI 2/0.625 perindopril erbumine/indapamide hemihydrate 2mg/0.625mg tablet blister pack
Sponsor
Alphapharm Pty Ltd
Company Detail Path
/organization/alphapharm-pty-ltd
Artg Date
2021-05-12
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
d2b7a8b82ac1aef6
Type
Standard
Back to TGA Approvals
PERISYL COMBI 2/0.625 perindopril erbumine/indapamide hemihydrate 2mg/0.625mg tablet blister pack - TGA Drug Approval Details
